Literature DB >> 17728544

In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation.

V Schmitz1, K-D Schaser, P Olschewski, P Neuhaus, G Puhl.   

Abstract

To determine whether microcirculatory changes following ischemia/reperfusion (I/R) may serve as predictors for subsequent graft dysfunction, we used noninvasive orthogonal polarization spectral (OPS) imaging to directly visualize and quantify cortical kidney microcirculation. In a total of 13 combined kidney/pancreas recipients, following reperfusion (5/30 min) microcirculatory parameters such as capillary diameter, functional capillary density (FCD) and red-blood-cell velocity (V(RBC)) of the renal graft were analyzed. From these parameters, a heterogeneity index (HI) and volumetric capillary blood flow (vCBF) were calculated. In addition, the extent of graft injury was determined by daily analysis of serum creatinine, blood urea nitrogen, C-reactive protein and systemic leukocyte count for 7 days post-transplant. At early reperfusion, a heterogeneous perfusion pattern with oscillating flow and scattered microvascular thrombosis of peritubular capillaries, resembling a 'no reflow', was observed. FCD was constant throughout the entire reperfusion period, whereas HI, capillary diameters, V(RBC) and vCBF increased. The latter showed a significant positive correlation with creatinine changes between days 1 and 3. So far our finding of a positive correlation of early microvascular changes (vCBF) and clinical parameters (creatinine) indicate a possible therapeutic implication of OPS imaging to predict early I/R-induced renal graft dysfunction. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17728544     DOI: 10.1159/000107683

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

1.  In vivo, label-free, three-dimensional quantitative imaging of kidney microcirculation using Doppler optical coherence tomography.

Authors:  Jeremiah Wierwille; Peter M Andrews; Maristela L Onozato; James Jiang; Alex Cable; Yu Chen
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

2.  The use of pulse pressure variation for predicting impairment of microcirculatory blood flow.

Authors:  Christoph R Behem; Michael F Graessler; Till Friedheim; Rahel Kluttig; Hans O Pinnschmidt; Anna Duprée; E Sebastian Debus; Daniel A Reuter; Sabine H Wipper; Constantin J C Trepte
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

3.  Donor pretreatment with tetrahydrobiopterin saves pancreatic isografts from ischemia reperfusion injury in a mouse model.

Authors:  M Maglione; R Oberhuber; B Cardini; K Watschinger; M Hermann; P Obrist; P Hengster; W Mark; S Schneeberger; G Werner-Felmayer; J Pratschke; R Margreiter; E R Werner; G Brandacher
Journal:  Am J Transplant       Date:  2010-10       Impact factor: 8.086

4.  Pretreatment of cisplatin in recipients attenuates post-transplantation pancreatitis in murine model.

Authors:  Sheng Yan; Yuan Ding; Fei Sun; Zhongjie Lu; Liang Xue; Xiangyan Liu; Mingqi Shuai; Chen Fang; Yan Wang; Hui Cheng; Lin Zhou; Ming H Zheng; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2012-02-01       Impact factor: 6.580

5.  Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.

Authors:  Fien A von Meijenfeldt; R Todd Stravitz; Jingwen Zhang; Jelle Adelmeijer; Yoh Zen; Valerie Durkalski; William M Lee; Ton Lisman
Journal:  Hepatology       Date:  2021-12-12       Impact factor: 17.298

6.  Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse.

Authors:  Sofia Nordling; Johan Brännström; Fredrik Carlsson; Bo Lu; Evelyn Salvaris; Alkwin Wanders; Jos Buijs; Sergio Estrada; Vladimir Tolmachev; Peter J Cowan; Tomas Lorant; Peetra U Magnusson
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.